News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Pfizer Inc. (PFE) Coy About Split, Spinoff Plans


1/29/2014 8:08:40 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

"We have not been approached by anybody that has an offer that would make those scenarios attractive, but we continually look for ways of increasing shareholder value and are open to any of those ideas," Pfizer (PFE +3.2%) CEO Ian Read tells Bloomberg post-earnings, responding to a question about a split of the company or interest in its products line from generic drugmakers. The stock's ahead today as results were boosted by a big drop in the stock float, a cut in operating expenses, and a two percentage point drop in the tax rate, but has badly lagged the broad pharmaceutical sector over the last year.

Help employers find you! Check out all the jobs and post your resume.

Read at Seeking Alpha


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES